ResMed | RMD - Operating Expenses


ResMed reported $925.21M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Ansell USD 414.45M 55.9M Jun/2025
Artivion USD 56.62M 195K Sep/2024
AtriCure USD 138.01M 3.95M Dec/2025
Baxter International USD 3.19B 554.4M Dec/2025
Cochlear AUD 460.1M 437.1M Jun/2025
Cooper Companies USD 924.8M 40.2M Sep/2025
CSL USD 2.87B 2.85B Jun/2025
Dexcom USD 936.6M 30.2M Dec/2025
Edwards Lifesciences USD 1.2B 71.3M Dec/2025
Fisher Paykel Healthcare NZD 802.4M 24.1M Dec/2025
Globus Medical USD 886.57M 730.06M Sep/2025
Haemonetics USD 134.99M 1.26M Dec/2025
Hologic USD 349.4M 447.1M Dec/2025
Idexx Laboratories USD 774.97M 24.58M Dec/2025
Inogen USD 49.14M 665K Sep/2024
Insulet USD 637.5M 48.9M Dec/2025
Integra LifeSciences USD 1.04B 620.66M Sep/2025
Intuitive Surgical USD 2B 263.6M Dec/2025
Masimo USD 147M 159.4M Sep/2025
Medtronic USD 7.28B 16M Dec/2025
Philips EUR 4.38B 405M Dec/2025
Ramsay Health Care AUD 8.72B 369.4M Jun/2025
ResMed USD 925.21M 51.98M Dec/2025
Sigma Healthcare AUD 1.68B 174.89M Dec/2024
Sonic Healthcare AUD 4.23B 2.14B Dec/2024
Steris USD 1.22B 28.8M Dec/2025
Teleflex USD 3.82B 3.22B Sep/2025
Thermo Fisher Scientific USD 9.91B 867M Dec/2025